Individuals at risk of beta-blocker discontinuation: A cohort study in 19,177 Chinese patients

Clinical Research in Cardiology

Volumn 99, Issue 5, 2010, Pages 277-284

  Wong, Martin C S ^a   Jiang, Johnny Y ^b   Su, Xuefen ^a   Wang, Haoxiang ^a   Tang, Jin Ling ^a   Griffiths, Sian M ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Antihypertensive drugs; Associated factors; Beta blockers; Discontinuation; Ethnic Chinese

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ANGINA PECTORIS; ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHINESE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; DRUG WITHDRAWAL; DYSLIPIDEMIA; FAMILY MEDICINE; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; GOUT; HEART DISEASE; HEART FAILURE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT TUMOR; MEDICAL SPECIALIST; NEPHROSIS; PATIENT COMPLIANCE; PRESCRIPTION; PROSTATE HYPERTROPHY; SEX DIFFERENCE; SOCIAL STATUS; STROKE; URINARY TRACT TUMOR;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HONG KONG; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; WITHHOLDING TREATMENT;

EID: 77954656611     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-010-0114-1     Document Type: Article

References (46)

1. Primatesta P, Brookes M, Poulter NR (2001) Improved hypertension management and control: results from the health survey for England, 1998. Hypertension 38:827-832
2. Izzo JL, Sica DA, Black HR (2008) Hypertension primer: the essentials of high blood pressure: basic science, population science, and clinical management, 4th edn. American Heart Association, USA
3. Lip GYH, Hall JE (2007). Comprehensive hypertension. Mosby
4. Collins R, Peto R, MacMahon S et al (1990) Blood pressure, stroke and coronary heart diseases: part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335:827-837
5. MacMahon S, Peto R, Cutler J et al (1990) Blood pressure, stroke and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for regression dilution bias. Lancet 335:765-774
6. Evidence-based clinical practice guidelines (CG 18 Hypertension in adults-Full guideline). Essential hypertension: managing adult patients in primary care. University of Newcastle upon Tyne, Centre for Health Services Research Report No. 111; 2004
7. HDFP Cooperative Group (1979) Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality in persons with high blood pressure, including mild hypertension. JAMA 242:2562-2571
8. SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 265:3255-3264
9. Materson BJ, Reda DJ, Cushman WC et al (1993) Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The department of veterans affairs cooperative study group on antihypertensive agents. N Engl J Med 328:914-921
10. Philipp T, Anlauf M, Distler A (1997) Randomized, double blind, multicenter comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group. BMJ 315:154-159
11. Joint National Committee (2003) The seventh report on prevention, detection, evaluation and treatment of high blood pressure. US Department of Health and Human Services, May 2003
12. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension (2003) Guidelines Committee. J Hypertens 21:1011-1053
13. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension (1999) J Hypertens 17:151-183
14. Wong MCS, Jiang JY, Lam A et al (2008) Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions. J Hum Hypertens 22:714-716
15. Ma J, Lee K-V, Stafford RS (2006) Changes in antihypertensive prescribing during US outpatient visits for uncomplicated hypertension between 1993 and 2004. Hypertension 48:846-852
16. Walley T, Duggan AK, Haycox AR et al (2003) Treatment for newly diagnosed hypertension: patterns of prescribing and antihypertensive effectiveness in the UK. J R Soc Med 96:525-531
17. Kabir Z, Feely J, Bennett K (2007) Primary care prescribing patterns in Ireland after the publication of large hypertension trials. BJCP 64(3):381-385
18. Kovacic D, Marinsek M, Gobec L et al (2008) Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure. Clin Res Cardiol 97:24-31
19. Dungen HD, Apostolovic S, Inkrot S et al (2008) Bisoprolol versus carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial. Clin Res Cardiol 97:578-586
20. van der Horst IC, Voors AA, van Veldhuisen DJ (2007) Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists? Clin Res Cardiol 96:193-195
21. Hoppe UC (2007) Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? AT1-receptor antagonists? Clin Res Cardiol 96:196-198
22. Wong MCS, Jiang JY, Gibbs T et al (2009) Factors associated with antihypertensive drug discontinuation among Chinese patients: a cohort study. Am J Hypertens 22:802-810
23. HA and clinical research-support, output and direction. http://www.ha.org.hk/ho/research-ethics/msdc-p181.pdf. Accessed on 06 Oct 2009
24. Wong MCS, Jiang JY, Tang JL et al (2008) Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data. BMC Health Serv Res 8:138
25. Population by-census, 2006, Hong Kong special administrative region, China. http://www.bycensus2006.gov.hk/data/data2/index. htm. Accessed 21 March 2009
26. Burke TA, Sturkenboom MC, Lu S et al (2006) Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens 24:1193-1200
27. Mazzaglia G, Mantovani LG, Sturkenboom MCJM et al (2005) Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens 23:2093-2100
28. Jones JK, Gorkin L, Lian JF et al (1995) Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of United Kingdom population. BMJ 311:293-295
29. Bourgault C, Senecal M, Brisson M et al (2005) Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study. J Hum Hypertens 19:607-613
30. Hoer A, Gothe H, Khan ZM et al (2007) Persistence and adherence with antihypertensive drug therapy in a German sickness fund population. J Hum Hypertens 21:744-746
31. Rogers PG, Bullman WR (1995) Prescription medicine compliance: a review of the baseline of knowledge. A report of the national council on patient information and education. J Pharmacoepidemiol 3:3-36
32. Van Wijk BLG, Klungel OH, Heerdink ER et al (2005) Rate and determinants of 10-year persistence with antihypertensive drugs. J Hypertens 23:2101-2107
33. Di Martino M, Veronesi C, Degli Esposti L et al (2008) Adherence to antihypertensive drug treatment and blood pressure control: a real practice analysis in Italy. J Hum Hypertens 22:51-53
34. Degli Esposti E, Sturani A, Di Martino M et al (2008) Long-term persistence with antihypertensive drugs in new patients. J Hum Hypertens 16:439-444
35. Inkster ME, Donnan PT, MacDonald TM et al (2006) Adherence to antihypertensive medication and association with patients and practice factors. J Hum Hypertens 20:295-297
36. Ko DT, Hebert PR, Coffey CS et al (2002) Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 288:351-357
37. Williams GH (1994) Hypertensive vascular disease. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fanci AS, Kasper DL et al (eds) Harrison's principles of internal medicine. McGraw-Hill, New York
38. Carter BL (2007) Adherence, quality of life, cost effectiveness, and the role of the pharmacist. In: Lip GYH, Hall JE (eds) Comprehensive hypertension. Chap. 92, pp 1119-1127
39. British Hypertension Society guidelines for hypertension management (1999) BMJ 319:630-635
40. National collaborating centre for chronic conditions (2006) Hypertension: management in adults in primary care: pharmacological update. Royal College of Physicians, London
41. Degli Esposti L, Degli Esposti E, Valpiani G et al (2002) A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clin Ther 24:1347-1357
42. Grymonpre RE, Didur CD, Montgomery PR et al (1998) Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother 32:749-754
43. Yuen YH, Chang S, Chong CK et al (1998) Drug utilization in a hospital general medical outpatient clinic with particular reference to antihypertensive and antidiabetic drugs. J Clin Pharm Ther 23:287-294
44. Cheung BM, Wong YL, Lau CP (2005) Queen Mary utilization of antihypertensive drugs study: use of antihypertensive drug classes in the hypertension clinic 1996-2004. Br J Clin Pharmacol 60:90-97
45. Damman K, de Boer RA, van Veldhuisen DJ (2008) Heart failure, aging and beta-blockers: the need for more data on tolerability and efficacy. Clin Res Cardiol 97:575-577
46. Doehner W, Anker SD (2008) Beta blockers and glucose metabolism in chronic heart failure: friend or foe? Clin Res Cardiol 97:21-23